Atorvastatin (a lipid-regulating drug) was the most prescribed item in 2021-22, with it being prescribed more than 3.2 million times, an increase of almost 200,000 (or 6.6%) since 2020-21.
Atorvastatin (cyffur sy’n rheoli lipidau) oedd yr eitem a ragnodwyd fwyaf yn 2021-22, a chafodd ei ragnodi fwy na 3.2 miliwn o weithiau (200,000), sef cynnydd o 6.6 (neu 5.1%) ers 2019-20.